Are There Any Resistance Issues Associated with Anthracenedione?
Resistance to anthracenedione, as with other chemotherapy agents, can occur. Cancer cells may develop mechanisms to evade the effects of the drug, such as increased efflux of the drug out of the cells or enhanced DNA repair capabilities. Research is ongoing to understand these resistance mechanisms and to develop strategies to overcome them, such as combination therapies with other anticancer agents.
